Search for: "Matter of Medical Analytics, Inc." Results 41 - 60 of 144
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2021, 8:01 am by William Ford, Victoria Gallegos
Mike Nagata, senior vice president of CACI International Inc.; retired Lt. [read post]
15 Mar 2021, 9:42 am by William Ford, Victoria Gallegos
The subcommittee will hear testimony from Joseph Kirschbaum, director of the Government Accountability Office; Bryan Clark, a senior fellow at the Hudson Institute; and William Conley, chief technology officer at Mercury Systems, Inc. [read post]
4 Jan 2021, 1:29 pm by Matt Gluck, Tia Sewell
Army Corps of Engineers, Connie Duckworth, chairman & CEO at ARZU Inc. and Razia Jan, founder & CEO of Razia’s Ray of Hope Foundation, will join Ambassador Paula Dobriansky, senior fellow at Harvard University’s Belfer Center, to analyze the gains Afghan women have made and how women’s economic opportunity can help prevent fighting and promote stability in Afghanistan. [read post]
2 Jan 2021, 1:01 pm
That decade-old matter is just as important today. [read post]
14 Dec 2020, 10:01 am by William Ford, Tia Sewell
” CSIS expert James Andrew Lewis will join Becky Burr, partner at Harris, Wiltshire & Grannis LLP, and Steve Crocker, CEO and Co-Founder of Shinkuro, Inc., to consider questions facing policymakers today on content moderation and privacy concerns and discuss what the future of internet governance should look like. [read post]
25 Jun 2020, 5:43 am by John Lewis
As we have cautioned before, arbitration rules do matter and must be carefully considered. [read post]
16 Jun 2020, 2:18 pm by Kevin LaCroix
Thus, Judge Anderson intensely focuses upon the following Capital One/Mandiant engagement timeline:   November 30, 2015: Capital One enters into a master services agreement (“MSA”) with FireEye, Inc. and Mandiant, and thereafter enters into periodic statements of work (“SOW”) and purchase orders with Mandiant pursuant to the MSA. [read post]
11 Jun 2020, 11:30 pm by Schachtman
More important, however, the invocation of Milward suggests that any alleged flaws in combining study results in a meta-analysis are always matters for the jury, no matter how arcane, technical, or threatening to validity they may be. [read post]
23 Jan 2020, 10:37 pm by Schachtman
All of plaintiffs’ epidemiology witnesses, and certainly all of defendants’ experts, implicitly if not explicitly embraced the proposition that analytical epidemiology was necessary to determine whether PDE5i medications can cause melanoma. [read post]
23 Dec 2019, 3:06 am
Ruling that statements made in patent filings by a trademark applicant (and by third parties) are probative evidence as to the descriptiveness of a term, the Board affirmed a Section 2(e)(1) mere descriptiveness refusal of SEQUENCING BY BINDING for "reagents for analysis of biological analytes; research laboratory analyzers for analysis of biological analytes for non-medical purposes devices for analysis of biological analytes for medical purposes;… [read post]
2 Oct 2019, 10:00 pm
Prometheus Laboratories, Inc., the Federal Circuit has never found one of these medical inventions eligible for patent protection. [read post]
6 Sep 2019, 11:43 am
That is, these lists merely articulate judgments (placement on the list) that is the product of applying data to an analytical model useful for separating those who belong on the list from those who do not. [read post]
18 May 2019, 9:27 am by MOTP
Apr. 26, 2019).While the resolution of the case pivots on issues of contract law in the leasing context, the lengthy portion of the opinion addressing the matter of attorneys fees [see cut & pasted below] will have much broader impact across a wide array of practice areas. [read post]
17 Dec 2018, 8:05 am by Bob Ambrogi
Elevator pitch: DataNovo offers a patented SaaS platform powered by AI to provide patent-specific solutions that include: (1) licensing analytics that map patents to commercial products to identify potential patent infringers and infringing products, and (2) prior art analytics to identify unique prior art to every U.S. patent. [read post]